No Data
No Data
Aslan Pharmaceuticals to Change ADS Ratio From 1 ADS to 25 Shrs to 1 ADS to 200 Shrs >ASLN
Aslan Pharmaceuticals to Change ADS Ratio From 1 ADS to 25 Shrs to 1 ADS to 200 Shrs >ASLN
ASLAN Pharmaceuticals Announces Plan to Implement ADS Ratio Change
SAN MATEO, Calif. and SINGAPORE, June 14, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (("ASLAN" or the "Company", NASDAQ:ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative
Asian Equities Traded in the US as American Depositary Receipts Drop Sharply in Thursday Trading
Asian equities traded in the US as American depositary receipts were moving sharply lower Thursday morning, falling 1.06% to 1,947.44 on the S&P Asia 50 ADR Index.
ASLAN Pharmaceuticals Files to Sell 61.9M Ordinary Shares for Holders
Asian Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading
Asian equities traded in the US as American depositary receipts opened the week trending higher Monday morning, rising 0.66% to 1,957.14 on the S&P Asia 50 ADR Index. From North Asia, the gainers were
Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Wednesday Trading
Asian equities traded in the US as American depositary receipts were trending sharply higher Wednesday morning, rising 1.38% to 1,936.34 on the S&P Asia 50 ADR Index. From North Asia, the gainers were
No Data